Operationalizing AI in Drug Development: From Infrastructure to Impact

AI is transforming drug development - but scaling impact requires more than models. In this panel, pharma leaders from J&J, AstraZeneca, Dash Bio share how modern platforms can enable self-serve analytics, faster collaboration, and reproducibility, driving real-world gains across oncology and R&D.